Medicalsystem Biotechnology Co., Ltd (SHE:300439)

China flag China · Delayed Price · Currency is CNY
10.09
+0.43 (4.45%)
Apr 29, 2026, 3:04 PM CST
-7.52%
Market Cap 3.71B
Revenue (ttm) 1.54B
Net Income (ttm) 63.20M
Shares Out 384.32M
EPS (ttm) 0.16
PE Ratio 60.38
Forward PE n/a
Dividend 0.13 (1.40%)
Ex-Dividend Date Jun 23, 2025
Volume 8,275,800
Average Volume 4,204,403
Open 9.73
Previous Close 9.66
Day's Range 9.73 - 10.17
52-Week Range 9.08 - 12.20
Beta 0.30
RSI 44.63
Earnings Date Apr 29, 2026

About SHE:300439

Medicalsystem Biotechnology Co., Ltd. engages in the research, development, production, and sales of in vitro diagnostic products in China. It is also involved in the provision of Three-party medical diagnosis services. The company offers automated chemistry analyzers; and automated chemiluminescence immunoassay analyzer; hematology analyzers and reagents; total laboratory automation system; mass spectrometry; and, blood lipid subfraction analyzer, and POCT.It also provides healthcare services. Medicalsystem Biotechnology Co., Ltd. was formerly... [Read more]

Sector Healthcare
Founded 2003
Employees 2,104
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300439
Full Company Profile

Financial Performance

In 2025, SHE:300439's revenue was 1.54 billion, a decrease of -11.67% compared to the previous year's 1.74 billion. Earnings were 63.20 million, a decrease of -75.50%.

Financial Statements

News

There is no news available yet.